AUS
NZ
UK
CA
USA
FRA
GER
ESP
ITA
NLD
PRT
SWE
GRC
IND
POL
BRA
ZAF
RUS
CHN
UAE
Healthcare
Theralase Technologies Secures Funding for New Growth Phase
September 26, 2024 02:53 AM AEST| By Team Kalkine MediaHighlights,Theralase raised $544,000 through a private placement to fund clinical trials and research.,The company focuses on treatments for non-muscle invasive bladder cancer and preclinical research on Rutherrin.,Theralase granted 12.34 million sto...
What Lies Ahead for Spectral Medical After a 13% Drop Following Impressive Growth?
September 25, 2024 03:50 AM AEST| By Team Kalkine MediaSpectral Medical Inc., operating within the,healthcare sector,, has recently seen its share price decrease by 15% over the past month. This decline has raised concerns among shareholders, yet it is important to note that the company’s performance ove...
Is Medexus Pharmaceuticals Poised for a Turnaround?
September 25, 2024 03:21 AM AEST| By Team Kalkine MediaReturn on Equity (ROE) is a key metric that serves as an indicator of a company's ability to generate returns on the equity invested by shareholders. For companies within the pharmaceuticals sector, such as Medexus Pharmaceuticals Inc. (,TSX:MDP,), R...
Charting New Territories: Cardiol Therapeutics Reaches a Milestone in Clinical Trials
September 25, 2024 12:27 AM AEST| By Team Kalkine MediaCardiol Therapeutics (,TSX:CRDL,) has successfully reached its enrollment goal of 100 patients for the ARCHER trial, a Phase II randomized, double-blind, placebo-controlled study. This trial is focused on assessing CardiolRx's efficacy in promoting m...
Leadership Shift: Voyageur Pharmaceuticals’ New Business Development VP
September 25, 2024 12:04 AM AEST| By Team Kalkine MediaVoyageur Pharmaceuticals Ltd, operating within the,healthcare sector,,has announced the appointment of Dr. Ibrahim Hashmi as Vice President of Business Development. This strategic addition aims to accelerate the company’s commercial initiatives and e...
Cardiol Therapeutics (TSX:CRDL) Achieves Milestone in ARCHER Trial for Acute Myocarditis
September 24, 2024 09:42 PM AEST| By Team Kalkine MediaCardiol Therapeutics Inc. (NASDAQ: CRDL) (TSX: CRDL), a clinical-stage life sciences company dedicated to developing innovative therapies for heart disease, has reached a significant milestone in its research efforts. The company has successfully enr...
Things to Know Before Andlauer Healthcare (TSX:AND) Goes Ex-Dividend Date
September 23, 2024 03:33 PM AEST| By Team Kalkine MediaInvestors eyeing dividend opportunities may want to consider Andlauer Healthcare Group Inc. (TSX:AND) before it goes ex-dividend. To receive the company's upcoming dividend payment, shares need to be purchased before the ex-dividend date of September...
Why Does Kovo HealthTech's Rise Leave Market Sentiment Wavering?
September 21, 2024 03:55 AM AEST| By Team Kalkine MediaKovo HealthTech Corporation , a player in the,Healthcare sector,, has recently seen its share price increase by 50% over the past month. This surge comes as welcome news for shareholders; however, it remains overshadowed by a substantial 67% decline...
What Extendicare's New Dividend Reveals About Corporate Health and Stability
September 21, 2024 03:43 AM AEST| By Team Kalkine MediaExtendicare Inc. , a prominent player in the,healthcare sector,, has announced a dividend payment of CA$0.04, scheduled for October 15th. This dividend equates to an annual yield of 5.2% based on the current stock price, aligning with industry averag...
BioHarvest Sciences Board Shake-Up
September 21, 2024 12:13 AM AEST| By Team Kalkine MediaBioHarvest Sciences Inc.,(OTC:CNVCF),has reported the resignation of David Ryan from his position as a director. Despite this change, Ryan will remain an integral part of the company's management team, continuing to fulfill his duties as vice preside...
Willow Biosciences (TSX:WLLW) Partners with API Manufacturer for Sustainable Ingredient Development
September 20, 2024 05:57 PM AEST| By Team Kalkine MediaWillow Biosciences Inc. (TSX:WLLW), a pioneering biotechnology company dedicated to transforming the industrial manufacturing landscape, has announced a new collaboration with a prominent Active Pharmaceutical Ingredient (API) manufacturer. This part...
Willow Biosciences Engages in Innovative Project with Leading API Manufacturer
September 20, 2024 04:32 AM AEST| By Team Kalkine MediaIn the,Healthcare sector,, Willow Biosciences Inc. has announced a second collaboration with a prominent Active Pharmaceutical Ingredient (API) manufacturer. This partnership aims to develop a more sustainable and cost-effective manufacturing route f...
Roquefort’s STAT-6 siRNA Effective in Trials, Eyes Licensing
September 20, 2024 03:44 AM AEST| By Team Kalkine MediaRoquefort Therapeutics has recently highlighted significant advancements in its STAT-6 siRNA program, providing an update on promising results obtained from a validated in vitro model of immunological disease. This novel therapeutic approach utilizes...
Breakthrough Device For Pediatric Sleep Apnea Approved By FDA
September 19, 2024 12:38 AM AEST| By Team Kalkine MediaVivos Therapeutics has announced the receipt of US Food and Drug Administration (FDA) approval for its oral medical device designed to treat moderate to severe obstructive sleep apnea (OSA) in children aged 6 to 17. This innovative device offers a no...
Immunic Unveils Lead Asset For Multiple Sclerosis At ECTRIMS
September 18, 2024 11:25 PM AEST| By Team Kalkine MediaImmunic Inc has presented significant data on its primary asset, vidofludimus calcium, at the 40th Congress of the European Committee for Treatment and Research in Multiple Sclerosis (ECTRIMS). This congress, held from September 18 to 20 in Copenhage...
MustGrow Partners With Agriculture Canada For Mustard Seed Breakthrough
September 18, 2024 03:03 AM AEST| By Team Kalkine MediaMustGrow Biologics Corp. (,TSXV:MGRO,) has received funding from Agriculture and Agri-Food Canada (AAFC) to explore the potential of mustard-derived ingredients for applications in human and animal health. This support, granted through the AgriScienc...
Voyageur Pharmaceuticals Appoints New Chief Science Officer
September 18, 2024 02:43 AM AEST| By Team Kalkine MediaVoyageur Pharmaceuticals Ltd (,TSXV:VM,) has announced a significant addition to its executive team with the appointment of Dr. Iryna Saranchova as the new Chief Science Officer. Dr. Saranchova joins Voyageur from MYND Life Sciences, where she held t...
Lisata Therapeutics Begins Second Cohort Treatment In Bile Duct Cancer Trial
September 18, 2024 02:26 AM AEST| By Team Kalkine MediaLisata Therapeutics Inc,(NASDAQ:LSTA),. has initiated treatment in the second-line cholangiocarcinoma (CCA) cohort of its BOLSTER trial. Cholangiocarcinoma, often referred to as bile duct cancer, is a rare and aggressive cancer with a five-year survi...
Savaria Chief Legal Officer & Corporate Secretary Sylvain Aubry Reduces Holding By 81%
September 17, 2024 05:12 AM AEST| By Team Kalkine MediaSavaria Corporation (,TSX:SIS,), a prominent player in the healthcare sector, has recently seen notable insider transactions. Sylvain Aubry, the Chief Legal Officer & Corporate Secretary, recently sold shares worth CA$415,000 at an average price of C...
Andlauer Healthcare Group Inc.: Financials Remain Robust Despite Recent Stock Weakness
September 14, 2024 04:13 AM AEST| By Team Kalkine MediaRecent performance data for Andlauer Healthcare Group (,TSX:AND,) has shown a 4.8% decline in its stock value over the past week. This decline may raise concerns for stakeholders, but a closer inspection of the company’s financial metrics could provi...
Canadian AI All-Stars: Unveiling the Top Stocks for 2025